3291 - 3300 of 6422 Results
Title
Year
-
OPENTitle: Trajectories of pain over 6 years in early Parkinson’s disease: ICICLE-PDJournal Name: Journal of NeurologyPublisher: Springer Science and Business Media LLCVol: 268Issue #: 12Start Page: 4759End Page: 4767Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1007/s00415-021-10586-7Best OA location URL: https://link.springer.com/content/pdf/10.1007/s00415-021-10586-7.pdfCitation Count: 11
-
OPENTitle: Memory enhancement by multidomain group cognitive training in patients with Parkinson’s disease and mild cognitive impairment: long-term effects of a multicenter randomized controlled trialJournal Name: Journal of NeurologyPublisher: Springer Science and Business Media LLCVol: 268Issue #: 12Start Page: 4655End Page: 4666Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1007/s00415-021-10568-9Best OA location URL: https://pub.dzne.de/record/155574Citation Count: 19
-
OPENTitle: Energy expenditure, body composition and dietary habits in progressive supranuclear palsyJournal Name: Journal of NeurologyPublisher: Springer Science and Business Media LLCVol: 269Issue #: 5Start Page: 2610End Page: 2618Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1007/s00415-021-10846-6Best OA location URL: https://link.springer.com/content/pdf/10.1007/s00415-021-10846-6.pdfCitation Count: 3
-
OPENTitle: Dual monoamine oxidase B and acetylcholine esterase inhibitors for treating movement and cognition deficits in a C. elegans model of Parkinson’s diseaseJournal Name: Medicinal Chemistry ResearchPublisher: Springer Science and Business Media LLCVol: 30Issue #: 5Start Page: 1166End Page: 1174Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1007/s00044-021-02720-xBest OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/8570587Citation Count: 4
-
OPENTitle: Olfaction, cholinergic basal forebrain degeneration, and cognition in early Parkinson diseaseJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 90Issue #:Start Page: 27End Page: 32Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2021.07.024Citation Count: 17
-
OPENTitle: North American survey on impact of the COVID-19 pandemic shutdown on DBS careJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 92Issue #:Start Page: 41End Page: 45Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2021.10.011Best OA location URL: http://www.prd-journal.com/article/S1353802021003667/pdfCitation Count: 8
-
OPENTitle: Exploratory analysis of the genetics of impulse control disorders in Parkinson's disease using genetic risk scoresJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 86Issue #:Start Page: 74End Page: 77Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2021.04.003Best OA location URL: https://hal.archives-ouvertes.fr/hal-03298502Citation Count: 8
-
OPENTitle: Effects of angiotensin type 1 receptor antagonists on Parkinson's disease progression: An exploratory study in the PPMI databaseJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 86Issue #:Start Page: 34End Page: 37Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2021.03.007Best OA location URL: https://repositorio.uca.edu.ar/handle/123456789/11625Citation Count: 12
-
OPENTitle: Duration of benefit per Dose: Carbidopa-Levodopa immediate release vs. extended release capsules (Rytary®)Journal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 82Issue #:Start Page: 133End Page: 137Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.parkreldis.2020.12.002Best OA location URL: http://www.prd-journal.com/article/S1353802020309007/pdfCitation Count: 5
-
OPENTitle: A French survey on the lockdown consequences of COVID-19 pandemic in Parkinson's disease. The ERCOPARK studyJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 89Issue #:Start Page: 128End Page: 133Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2021.07.013Best OA location URL: http://www.prd-journal.com/article/S1353802021002625/pdfCitation Count: 24